SCHEMBL12232109

SCHEMBL12232109

c1ccc(-n2c(-c3cc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)ccc3-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)nc3ccccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.45
▸ RECQL P46063 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ CYP11B2 P19099 2/20 0.44
▸ MAPT P10636 2/20 0.43
▸ GSR P00390 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ RAD51 Q06609 1/20 0.40
▸ RPS6KA5 O75582 1/20 0.40
▸ MDM2 Q00987 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ G6PD P11413 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ LCK P06239 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12232068 0.98 RECQL (0.47) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232114 0.95 ESR1 (0.49) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232087 0.91 ESR1 (0.49) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232086 0.89 RECQL (0.43) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232067 0.87 ESR1 (0.52) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232106 0.87 ESR1 (0.55) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232069 0.87 ESR1 (0.55) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232104 0.87 ESR1 (0.55) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL16484904 0.85 MAPT (0.42) AOC3RECQLESR1ESR2CYP11B2
SCHEMBL12232034 0.83 MAPT (0.43) AOC3RECQLESR1ESR2CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772632-B2 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2014-07-08 — — US disclosed
US-8772632-B2 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2014-07-08 — — US disclosed
US-20130274471-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME IN KYU-YEON (KR) 2013-10-17 — — US disclosed
US-20130274471-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME IN KYU-YEON (KR) 2013-10-17 — — US disclosed
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-27 — — US disclosed
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME PPOX, AOX1, OR10J3 AOC3 153/4885RECQL 1511/4885ESR1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback